News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
152 Results
Type
Article (22)
Press Release (130)
Section
Business (51)
Deals (2)
Drug Development (17)
FDA (2)
Job Trends (2)
News (67)
Policy (3)
Tag
Alliances (19)
Approvals (2)
Artificial intelligence (1)
Clinical research (12)
Collaboration (2)
COVID-19 (2)
Data (1)
Diabetes (1)
Diagnostics (1)
Drug discovery (1)
Earnings (7)
Events (20)
FDA (2)
Funding (1)
GLP-1 (1)
Government (1)
Healthcare (1)
Infectious disease (2)
IPO (4)
Job creations (1)
Layoffs (1)
Legal (1)
Medical device (2)
Medtech (2)
Mergers & acquisitions (2)
Metabolic disorders (8)
NextGen: Class of 2025 (1)
Northern California (6)
Obesity (8)
People (17)
Phase I (4)
Phase II (7)
Pipeline (3)
Preclinical (3)
Real estate (1)
Regulatory (2)
Startups (1)
United States (12)
Venture capitalists (1)
Weight loss (4)
Date
Last 30 days (3)
Last 365 days (28)
2025 (3)
2024 (28)
2023 (6)
2022 (25)
2021 (16)
2020 (9)
2019 (4)
2018 (2)
2017 (4)
2016 (4)
2015 (10)
2014 (4)
2013 (6)
2012 (5)
2011 (7)
2010 (3)
Location
Arizona (1)
Asia (11)
California (8)
China (1)
Delaware (1)
Europe (15)
Idaho (1)
Massachusetts (1)
Northern California (6)
152 Results for "bioage".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Weight loss
BioAge Drops Lead Obesity Asset Months After IPO
It’s been a rocky few months for BioAge Labs, which shuttered a Phase II trial of its lead candidate azelaprag Tuesday after the molecule caused liver-based side effects.
January 28, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform Programs
January 29, 2025
·
5 min read
IPO
Lilly Partner BioAge Files for IPO to Advance Obesity Candidate
BioAge will use the proceeds from the initial public offering to move its oral apelin receptor agonist azelaprag past its Phase III STRIDES study and into a registrational Phase III trial.
September 4, 2024
·
2 min read
·
Tristan Manalac
Press Releases
BioAge Labs to Present at Upcoming Investor Conferences
November 22, 2024
·
1 min read
Obesity
BioAge Crashes After Axing Phase II Obesity Study
The discontinuation of STRIDES is a rare stumble for the next-generation obesity field and comes just weeks after Amgen announced underwhelming mid-stage data for MariTide.
December 9, 2024
·
2 min read
·
Tristan Manalac
Press Releases
BioAge Labs to Present at Goldman Sachs “Year-Ahead” Catalyst Clinic
December 6, 2024
·
1 min read
Press Releases
BioAge Labs to Present at Jefferies London Healthcare Conference
October 24, 2024
·
1 min read
Press Releases
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
November 4, 2024
·
3 min read
Business
BioAge Labs Announces Inaugural Scientific Advisory Board to Support Advancement of Novel Therapeutics Targeting Metabolic Aging
BioAge Labs, Inc. today announced the formation of its Scientific Advisory Board (SAB).
May 15, 2024
·
5 min read
Press Releases
BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions
December 18, 2024
·
5 min read
1 of 16
Next
